SecBot SecBot
SECBOTREPLAY Home › Report › MLYS

MLYS · CEO Jon Congleton and CMO David Malcom Rodman sold a combined $679K of…

Mineralys Therapeutics, Inc. · CLUSTER filed Jul 15, 2026 at 20:58 ET

At the news

NEUTRALIMPACT 3/10

CLUSTER filed Jul 15, 2026 at 20:58 ET

CEO Jon Congleton and CMO David Malcom Rodman sold a combined $679K of MLYS stock in open-market sales on July 13, 2026, following derivative exercises by the CMO. At a $2.3B market cap, the sales represent ~0.03% of market cap, well below the 0.1% threshold for materiality. The CMO's exercises were non-cash events; the sales appear to be routine post-vesting liquidity transactions, not a bearish signal.

  • CEO Jon Congleton sold 10,700 shares at $27.24 for $291K on July 13, 2026.
  • CMO David Malcom Rodman sold 14,058 shares at $27.58 for $388K on July 13, 2026.
  • CMO also exercised multiple derivative tranches (non-cash) on July 13, 2026.
  • Total open-market sales: $679K, representing ~0.03% of MLYS's $2.3B market cap.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access